BMED vs IYH

iShares Health Innovation Active ETF against iShares U.S. Healthcare ETF: cost, size, returns, what they hold and how much of it is the same.

Overlap by weight
38%
31 shared positions
Fee gap
18 bp
IYH is cheaper
1-year return gap
5.0 pts
BMED is ahead
Larger fund
IYH
$4.2B

Side by side

BMEDIYH
FundiShares Health Innovation Active ETFiShares U.S. Healthcare ETF
IssueriSharesiShares
CategoryInternet & InnovationHealth Care
Expense ratio0.55%0.37%
Assets$14M$4.2B
Average daily dollar volume$67K$53M
ListedSep 29, 2020Jun 12, 2000
FrenzyCap score3170
1-month return+3.9%+3.1%
3-month return+11.5%+6.1%
Year to date+13.3%+10.8%
1-year return+23.3%+18.2%
30-day volatility19.0%14.0%
Worst drawdown, 1 year−14.8%−10.9%
Trailing 12-month yield0.24%1.11%
Holdings60104
Top 10 weight43.1%58.7%
Look-through P/E71.337.7
Holdings vs fair value+0.4%+1.3%
Holdings above 200-day average85%85%
Net flow, latest 3 reported months$0 thru Jul 2026+$432M thru Jul 2026
30-day implied volatility23.6%20.1%
Holdings as ofas of Oct 8, 2026issuer dataas of Oct 8, 2026issuer data

Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.

Largest shared holdings

74% of BMED · 53% of IYH
HoldingBMEDIYH
ABBV4.92%7.66%
JNJ4.14%9.81%
TMO4.37%3.85%
MRK3.12%5.59%
GILD5.06%2.90%
AMGN2.43%3.49%
DHR5.22%2.18%
VRTX3.31%2.03%
PFE1.52%2.52%
BMY1.35%1.93%
ABT1.28%2.71%
MRNA5.09%1.14%
EW2.97%0.76%
A1.25%0.75%
IQV3.70%0.67%
WAT3.67%0.67%
ILMN2.29%0.64%
RVMD0.58%0.57%
BIIB3.49%0.51%
DXCM2.44%0.50%
GH1.44%0.34%
INCY0.73%0.30%
ROIV1.31%0.28%
CRL1.53%0.23%
NBIX1.37%0.22%

Sector mix of the stock holdings

SectorBMEDIYHGap
Health Care64.6%90.1%−25.5%
Technology24.6%9.6%+15.0%
Financials0.6%0.0%+0.6%
Industrials0.0%0.1%−0.1%

More: full overlap table · BMED holdings · IYH holdings

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.